Since its establishment almost 50 years ago the Börsen-Zeitung is the only “pure” financial newspaper in Germany. From the very beginning it has accompanies the development of the financial centre n Frankfurt into the seat of the European Central Bank. A long time ago the Börsen-Zeitung became an institution in the specialised niche of the financial markets. In many respects it is considered by both market participants and market observers to be the flagship for objective opinion, also because the focus of the Börsen-Zeitung places consistent emphasis on financial markets, company reports and banking. It offers rapid and reliable access to all important information. The Börsen-Zeitung constitutes part of the daily reading in the Deutsche Bundesbank, in the Land Central Banks, in economic departments, of economic analysts of all persuasions and also increasingly of those responsible for the financial policy of the public sector as well as, most recently, at the European Central Bank.

EURO am Sonntag - The only business newspaper published on Sunday.

• focused on facts on stock markets and money monitoring
  
• targeted at private capital investors
  
• crucial future investment markets analysed, e.g. biotechnology, computers, IT, property, funds, insurance
  
• Big target group: The german private investor market encloses nearly 30% of german population
  
• clear, concise information
  
• innovative layout and format
  
• good readability
  
• deliverable to households at no extra cost
  
• newspaper format enables last-minute printing/advertising deadlines

Target group: - decision-makers

• 25-50 years
  
• pro-active investors
  
• experienced with stock markets
  
• educated above average
  
• regular reader of business titles

Journal of Commercial Biotechnology has established itself as the leading international forum for latest thinking and practice in biotech business, strategy and management. This unique quarterly provides insightful analyses of the commercial, legal and regulatory issues affecting the entire biotech industry - from SMEs and pharma to those involved in investment, regulation, R&D and academia. Now in its eighth volume, under the guidance of an international editorial board, it publishes:

• Applied quantitative and qualitative research
  
• Case studies
  
• Legal and regulatory updates
  
• Financial account reviews

Articles scheduled to appear include:

• Becoming the partner of choice: Measuring, managing and changing partnering capabilities at Eli Lily and Company
• Genetic testing services in Europe: Quality assurance and policy issues
  
• The use of real options to evaluate risk in the biotech industry
  
• Patenting human genes: Strategies for winning the public debate
  
• Venture capital activity in Europe
  

To subscribe, visit www.henrystewart.com/journals/hspindex.htm - quoting AU as “your ref”.
Email steve@hspublications.co.uk for a sample copy.

PrivateEquityOnline.com is the premier multimedia portal tracking Europe’s private equity and venture capital industry. Whether you’re an investor, intermediary, entrepreneur or from the institutional buy-side, you get the inside track on the people, deals and funds shaping the industry.

PrivateEquityOnline.com is published by the leading financial markets publisher, investoraccess.com, part of the Euromoney Institutional Investor Group. www.privateequityonline.com

TeleTech Financing Week (TFW) is the premier news publication covering financial activity in both the technology and telecom sectors. Every week, investment bankers, CFOs, and venture capitalists look to TFW for exclusive information from our investigative reporting staff to get a leg up on their competitors. TFW covers deals and firms, VC investment news and strategies, start-up companies seeking funding, alliances and mergers and global coverage of all sectors within technology and telecommunications. For a Trial Subscription, visit us at www.teletechfinance.com or call customer service, U.S.: 212-224-3800/U.K. 44 (0) 207-779-8972/Hong Kong: 852-2842-6950.

Venture Capital Report is the UK’s foremost Business Angels Network, matching entrepreneurs to investors for 20 years. VCR’s monthly report features 8-10 screened investment opportunities, summarised into comprehensive 5-6 page articles. VCR covers all industry sectors with investment sought ranging from £100,000 to £1m. For more information visit www.vcr1978.com

Thomson Financial Venture Economics is your complete information solution covering the global private equity and venture capital industry. From European Venture Capital Journal (evcj.com), PEW, VCJ and Buy-Outs, through to the unique on-line private equity database, VentureXpert Web covering almost 40 years of global activity, TF Venture Economics is your essential partner in private equity.